In Silico & Data Insights Blog

BiotechClinicalCRODiscoveryDrug DiscoveryIn Silico & Data InsightsPharmaceuticalPre-ClinicalPress ReleasesRegulatory SubmissionsSEND Advantage Services

Instem Acquires PDS Life Sciences to Help Clients Bring Life Enhancing Products to Market Faster and More Efficiently

Instem Team

September 1, 2021

Acquisition of PDS Life Sciences Consolidates Non-Clinical Market; Further Extends Instem’s Leadership in Study Management and Regulatory SEND Submission Support

CROIn Silico & Data InsightsLeadscope Model ApplierPharmaceuticalPredictive ToxicologyPress ReleasesToxicology

Instem to Release Next Edition of its Leading Computational Toxicology Software Suite

Instem Team

July 29, 2021

Powerful New In Silico Models and First-to-Market Software Capabilities to Deliver Further Efficiencies and Increased Regulatory Compliance

Stay up to Date

Get expert tips, industry news, and fresh content delivered to your inbox.